With the Companys patented Nitric Oxide gas generating and delivery system and its proprietary and patented Nitric Oxide micro tablet medium manufacturing technology the Company has the potential to make a significant and life changing difference in the clinical use of Nitric Oxide in standardized and accepted clinical treatment practices across the world, initially in the treatment of mutating drug-resistant tuberculosis and Swine Flu (H1N1), Influenza A, and other non-clinical uses. Nitric Oxide – Tuberculosis


Hinterlasse eine Antwort

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

Erforderlich